Opioids and opioid receptors in the enteric nervous system: From a problem in opioid analgesia to a possible new prokinetic therapy in humans

Neuroscience Letters

Volumn 361, Issue 1-3, 2004, Pages 192-195

  Holzer, Peter ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Alvimopan; Constipation; Enteric nervous system; Intestinal peristalsis; N methylnaltrexone; Opioid induced bowel dysfunction; Peripherally restricted opioid receptor antagonists; Prokinetic effects

Indexed keywords

17 METHYLNALTREXONE; ALVIMOPAN; ANALGESIC AGENT; ATROPINE; HEXAMETHONIUM; MORPHINE; NORADRENALIN; OPIATE ANTAGONIST; OPIATE DERIVATIVE; OPIATE RECEPTOR;

ABDOMINAL DISTENSION; ANALGESIA; CLINICAL TRIAL; CONSTIPATION; GASTROESOPHAGEAL REFLUX; HUMAN; INTESTINE INNERVATION; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY;

ANALGESICS, OPIOID; ANIMALS; CONSTIPATION; ENTERIC NERVOUS SYSTEM; GASTROINTESTINAL MOTILITY; HUMANS; NALTREXONE; NARCOTIC ANTAGONISTS; PIPERIDINES; QUATERNARY AMMONIUM COMPOUNDS; RECEPTORS, OPIOID;

EID: 2342594524     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2003.12.004     Document Type: Short Survey

References (31)

1. Bauer A.J., Sarr M.G., Szurszewski J.H. Opioids inhibit neuromuscular transmission in circular muscle of human and baboon jejunum. Gastroenterology. 101:1991;970-976
2. Calignano A., Moncada S., Di Rosa M. Endogenous nitric oxide modulates morphine-induced constipation. Biochem. Biophys. Res. Commun. 181:1991;889-893
3. Chamouard P., Klein A., Martin E., Adloff M., Angel F. Regulatory role of enteric kappa opioid receptors in human colonic motility. Life Sci. 53:1993;1149-1156
4. Cosentino M., Marino F., De Ponti F., Giaroni C., Somaini L., Leoni O., Lecchini S., Frigo G. Tonic modulation of neurotransmitter release in the guinea-pig myenteric plexus: effect of mu and kappa opioid receptor blockade and of chronic sympathetic denervation. Neurosci. Lett. 194:1995;185-188
5. Costa M., Brookes S.J.H., Steele P.A., Gibbins I., Burcher E., Kandiah C.J. Neurochemical classification of myenteric neurons in the guinea-pig ileum. Neuroscience. 75:1996;949-967
6. De Luca A., Coupar I.M. Insights into opioid action in the intestinal tract. Pharmacol. Ther. 69:1996;103-115
7. De Ponti F., Giaroni C., Cosentino M., Lecchini S., Frigo G. Adrenergic mechanisms in the control of gastrointestinal motility: from basic science to clinical applications. Pharmacol. Ther. 69:1996;59-78
8. Donnerer J., Holzer P., Lembeck F. Release of dynorphin, somatostatin and substance P from the vascularly perfused small intestine of the guinea-pig during peristalsis. Br. J. Pharmacol. 83:1984;919-925
9. Fickel J., Bagnol D., Watson S.J., Akil H. Opioid receptor expression in the rat gastrointestinal tract: a quantitative study with comparison to the brain. Mol. Brain Res. 46:1997;1-8
10. Foss J.F. A review of the potential role of methylnaltrexone in opioid bowel dysfunction. Am. J. Surg. 182:(Suppl.):2001;19S-26S
11. Furness J.B. Types of neurons in the enteric nervous system. J. Auton. Nerv. Syst. 81:2000;87-96
12. Hawkes N.D., Rhodes J., Evans B.K., Rhodes P., Hawthorne A.B., Thomas G.A. Naloxone treatment for irritable bowel syndrome - a randomized controlled trial with an oral formulation. Aliment. Pharmacol. Ther. 16:2002;1649-1654
13. Heinemann A., Holzer P. Stimulant action of pituitary adenylate cyclase-activating peptide on normal and drug-compromised peristalsis in the guinea-pig intestine. Br. J. Pharmacol. 127:1999;763-771
14. Hirning L.D., Porreca F., Burks T.F. Mu, but not kappa, opioid agonists induce contractions of the canine small intestine ex vivo. Eur. J. Pharmacol. 109:1985;49-54
15. 2 receptor-mediated control of peristaltic propulsion in the guinea-pig small intestine in vitro. Neuropharmacology. 37:1998;131-138
16. Holzer P., Schicho R., Holzer-Petsche U., Lippe I.T. The gut as a neurological organ. Wiener Klin. Wochenschr. 113:2001;647-660
17. Jurna I., Kaiser R., Kretz O., Baldauf J. Oral naloxone reduces constipation but not antinociception from oral morphine in the rat. Neurosci. Lett. 142:1992;62-64
18. Kojima Y., Takahashi T., Fujina M., Owyang C. Inhibition of cholinergic transmission by opiates in ileal myenteric plexus is mediated by kappa receptor. Involvement of regulatory inhibitory G protein and calcium N-channels. J. Pharmacol. Exp. Ther. 268:1994;965-970
19. Kreek M.J., Schaefer R.A., Hahn E.F., Fishman J. Naloxone, a specific opioid antagonist, reverses chronic idiopathic constipation. Lancet. 1:1983;261-262
20. Kurz A., Sessler D.I. Opioid-induced bowel dysfunction: pathophysiology and potential new therapies. Drugs. 63:2003;649-671
21. Lenard I., Halmai V., Bartho L. Morphine contracts the guinea pig ileal circular muscle by interfering with a nitric oxide mediated tonic inhibition. Digestion. 60:1999;562-566
22. Liu S.S., Hodgson P.S., Carpenter R.L., Fricke J.R. ADL 8-2698, a trans-3, 4-dimethyl-4-(3-hydroxyphenyl) piperidine, prevents gastrointestinal effects of intravenous morphine without affecting analgesia. Clin. Pharmacol. Ther. 69:2001;66-71
23. Poonyachoti S., Portoghese P.S., Brown D.R. Characterization of opioid receptors modulating neurogenic contractions of circular muscle from porcine ileum and evidence that delta- and kappa-opioid receptors are coexpressed in myenteric neurons. J. Pharmacol. Exp. Ther. 297:2001;69-77
24. Schang J.C., Devroede G. Beneficial effects of naloxone in a patient with intestinal pseudoobstruction. Am. J. Gastroenterol. 80:1985;407-411
25. Schmidt W.K. Alvimopan (ADL 8-2698) is a novel peripheral opioid antagonist. Am. J. Surg. 182:(Suppl.):2001;27S-38S
26. Shahbazian A., Heinemann A., Schmidhammer H., Beubler E., Holzer-Petsche U., Holzer P. Involvement of mu- and kappa-, but not delta-, opioid receptors in the peristaltic motor depression caused by endogenous and exogenous opioids in the guinea-pig intestine. Br. J. Pharmacol. 135:2002;741-750
27. Sternini C., Spann M., Anton B., Keith D.E., Bunnett N.W., von Zastrow M., Evans C., Brecha N.C. Agonist-selective endocytosis of mu opioid receptor by neurons in vivo. Proc. Natl. Acad. Sci. USA. 93:1996;9241-9246
28. Sykes N.P. An investigation of the ability of oral naloxone to correct opioid-related constipation in patients with advanced cancer. Palliat. Med. 10:1996;135-144
29. Taguchi A., Sharma N., Saleem R.M., Sessler D.I., Carpenter R.L., Seyedsadr M., Kurz A. Selective postoperative inhibition of gastrointestinal opioid receptors. N. Engl. J. Med. 345:2001;935-940
30. Tonini M., Waterman S.A., Candura S.M., Coccini T., Costa M. Sites of action of morphine on the ascending excitatory reflex in the guinea-pig small intestine. Neurosci. Lett. 144:1992;195-198
31. Yuan C.S., Foss J.F., Moss J. Effects of methylnaltrexone on morphine-induced inhibition of contraction in isolated guinea-pig ileum and human intestine. Eur. J. Pharmacol. 276:1995;107-111